| Name | S07-1066 |
|---|
| Description | S07-1066 is an aldo-keto reductase 1C3 (AKR1C3) inhibitor, synergizing doxorubicin (DOX) cytotoxicity. S07-1066 selectively blocks AKR1C3-mediated reduction of DOX, and reverses the DOX resistance in overexpressing AKR1C3 cells[1]. |
|---|---|
| Related Catalog | |
| Target |
AKR1C3[1] |
| References |
| Molecular Formula | C16H11Cl2FO2 |
|---|---|
| Molecular Weight | 325.16 |